Breztri Aerosphere vs Fasenra
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Breztri Aerosphere | US Fasenra | |
|---|---|---|
| Generic name | budesonide/glycopyrrolate/formoterol | benralizumab |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | IL-5 Receptor Antagonist (Biologic) |
| Treats | COPD | Severe eosinophilic asthma |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | AstraZeneca |
| Year approved | 2020 | 2017 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $120M | $80M |
| Common side effects | Respiratory infections, Thrush, Cough, Headache | Headache, Sore throat, Allergic reactions, Injection site reactions |
Breztri Aerosphere
Frequently asked questions
Is Breztri Aerosphere or Fasenra better?
Neither is universally "better." Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Fasenra (benralizumab) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Breztri Aerosphere and Fasenra?
Breztri Aerosphere is a Inhaled Corticosteroid + LAMA + LABA made by AstraZeneca, while Fasenra is a IL-5 Receptor Antagonist (Biologic) made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Breztri Aerosphere has the larger estimated TV advertising budget of the two.